Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL‐24 enhances the antitumor effect of temozolomide against melanoma

BACKGROUND: Temozolomide (TMZ) is widely used to treat melanoma; however, response rates to TMZ are low because of rapid and frequent resistance. Conditionally, replicative adenoviruses (CRAds) are an effective and promising approach. The receptor for adenovirus is coxsackie‐adenovirus receptor (CAR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Autores principales: Yang, Ming, Yang, Chunsheng, Tao, Yingkai, Tang, Jianqin, Huang, Qian, Guo, Wenwen, Feng, Shouxin, Jiang, Aijun, Xu, Xifeng, Jiang, Guan, Liu, Yanqun
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308089/
https://ncbi.nlm.nih.gov/pubmed/30406970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1843
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares